Sadleir Laboratories is a Western Australia-based medical technology company specializing in the development of advanced intravenous drug delivery systems to enhance patient safety and workflow efficiency. Their flagship innovation, IRIS (Increasing Rate Infusion System), is a patented test dose syringe system designed to improve early detection of drug anaphylaxis, reduce adverse reaction severity, and support seamless integration into clinical practice. The organization is driven by experienced researchers and clinicians, with a strong focus on reducing perioperative hypersensitivity through evidence-backed innovation.
Is this your organisation?
Claim this profile to add your story, team and milestones.